---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-065371"
form_type: "8-K"
ticker: "DNTH"
cik: "0001690585"
company_name: "Dianthus Therapeutics, Inc. /DE/"
filed_at: "2024-05-28T23:59:59+00:00"
generated_at: "2026-06-01T08:07:11.987219+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Dianthus shareholders approve 2.93M share increase to stock option plan

## Summary
- Stockholders approved an amendment increasing shares reserved under the stock option plan by 2,931,820 shares.
- Evergreen provision raised from 4% to 5% of outstanding shares annually through 2028; plan expiration extended to March 14, 2034.
- Class III directors Leon O. Moulder Jr. and Alison F. Lawton elected; advisory votes on executive compensation approved with 23.0M votes for, 26.8K against.
- Stockholders ratified Deloitte as independent auditor for FY2024 with 24.1M votes for.
- Advisory vote on executive compensation frequency set to every year based on 23.0M votes for one-year interval.

## SEC filing metadata
- accession: 0000950170-24-065371
- form_type: 8-K
- ticker: DNTH
- cik: 0001690585
- company_name: Dianthus Therapeutics, Inc. /DE/
- filed_at: 2024-05-28T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.07, 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1690585/000095017024065371/0000950170-24-065371-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1690585/000095017024065371/dnth-20240523.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-065371
- JSON: https://secwatch.observer/filing/0000950170-24-065371.json
- Plain text: https://secwatch.observer/filing/0000950170-24-065371.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.